Nonacneiform

Not only were acne cases tested, but also the blood in various nonacneiform skin diseases, and also patients without any skin affection.

Most common events across all dosing regimens included diarrhea (64%), nonacneiform rash (60%), liver enzyme abnormalities (50%), fatigue (48%), nausea (45%), and photosensitivity (40%).

The most common inflammatory side effects for the entire cohort included arthralgias/myalgias (32.9%), nonacneiform rash (28.0%), pyrexia (25.5%), and erythema nodosum (11.2%), although side effects differed across the class of therapy.